Literature DB >> 11737074

Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease.

J F Subra1, G Renier, P Reboul, F Tollis, R Boivinet, P Schwartz, A Chevailler.   

Abstract

An increased prevalence of autoimmune diseases such as rheumatoid arthritis has been demonstrated in silica-exposed patients. The aim of this study was to determine the peripheral blood lymphocyte phenotype in a population of silicotic workers employed in the slate mines of the district. Silicosis was assessed in 58 patients according to the International Labor Office's criteria. Clinical and biological data including flow cytometric evaluation of the lymphocyte subsets were compared with those from 41 healthy volunteers. The silicotic patients had a higher prevalence of autoimmune diseases (6/58 versus 0/41: P < 0.05) and of elevated antinuclear antibody titres compared to the control group. A very significant decrease of total lymphocyte count (P < 0.001) involving B, T and Natural Killer cells was found in silicotic patients as compared with matched healthy volunteers. A significant increase in the percentage of activated T cells (12.3%) was observed in the silicotic group as compared to 6.5% in the control group (P = 5 x 10(-5)). Our results show that in silicotic patients, the absolute number of circulating lymphocytes is diminished with an increased proportion of activated T cells. Whether these findings could predispose to the development of autoimmune disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737074      PMCID: PMC1906221          DOI: 10.1046/j.1365-2249.2001.01696.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Soluble Fas mRNA is dominantly expressed in cases with silicosis.

Authors:  T Otsuki; H Sakaguchi; A Tomokuni; T Aikoh; T Matsuki; Y Kawakami; M Kusaka; H Ueki; S Kita; A Ueki
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

2.  Phenotyping of peripheral blood lymphocytes in adult coeliac disease.

Authors:  A Di Sabatino; E Bertrandi; M Casadei Maldini; F Pennese; F Proietti; G R Corazza
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  Activation-induced cell death in human peripheral blood lymphocytes after stimulation with silicate in vitro.

Authors:  T Aikoh; A Tomokuni; T Matsukii; F Hyodoh; H Ueki; T Otsuki; A Ueki
Journal:  Int J Oncol       Date:  1998-06       Impact factor: 5.650

Review 4.  ANCA-associated diseases and silica exposure.

Authors:  G Gregorini; P Tira; J Frizza; P C D'Haese; M M Elseviers; G Nuyts; R Maiorca; M E De Broe
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  Silicon nephropathy and myeloperoxidase antibodies.

Authors:  A Chevailler; F Carrere; G Renier; D Hurez; J F Subra; P Reboul; P Riberi; C Masson
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

6.  Antimyeloperoxidase antibodies in individuals with occupational exposure to silica.

Authors:  I Wichmann; J Sanchez-Roman; J Morales; M J Castillo; C Ocaña; A Nuñez-Roldan
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

7.  T-lymphocyte activation in the enlarged thoracic lymph nodes of rats with silicosis.

Authors:  H Garn; A Friedetzky; G S Davis; D R Hemenway; D Gemsa
Journal:  Am J Respir Cell Mol Biol       Date:  1997-03       Impact factor: 6.914

8.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

9.  Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.

Authors:  L Georgescu; R K Vakkalanka; K B Elkon; M K Crow
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Polyclonal human T-cell activation by silicate in vitro.

Authors:  A Ueki; M Yamaguchi; H Ueki; Y Watanabe; G Ohsawa; K Kinugawa; Y Kawakami; F Hyodoh
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more
  7 in total

1.  Progressive multifocal leukoencephalopathy in a patient with silicosis.

Authors:  Alexandre Bonnet; Anne Kerbrat; Pierre Tattevin; Anne Salmon; Stéphane Jouneau; Gilles Edan; Jacques Gasnault
Journal:  J Neurol       Date:  2016-07-14       Impact factor: 4.849

Review 2.  Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?

Authors:  C Beauvillain; Y Delneste; G Renier; P Jeannin; J F Subra; A Chevailler
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 3.  Lymphopenia and autoimmune diseases.

Authors:  Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2004-06-22       Impact factor: 5.156

4.  Acute tubular necrosis after ingestion of a fertilizer containing sodium silicate.

Authors:  Hyeon Woo Lee; Yong Jun Choi; Se Won Oh; Hye Kyeong Park; Kum Hyun Han; Han Seong Kim; Sang Youb Han
Journal:  Case Rep Nephrol       Date:  2014-12-10

5.  Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact.

Authors:  Tian Yang; Jinyuan Wang; Yamei Pang; Xiaomin Dang; Hui Ren; Ya Liu; Mingwei Chen; Dong Shang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

6.  Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang; Jui-Hung Yen; Wen-Chi Lin
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

7.  T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown.

Authors:  Benoit Brilland; Céline Beauvillain; Gery Mazurkiewicz; Pierre Rucay; Yves Roquelaure; Julie Tabiasco; Emeline Vinatier; Jérémie Riou; Pascale Jeannin; Gilles Renier; Jean-François Subra; Jean-François Augusto
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.